PPARγ was originally studied for its role in lipid and glucose metabolism, with its preferential ligands, the thiazolidinediones, currently being widely used in the pharmacological management of type 2 diabetes mellitus (e.g., pioglitazone, Table 1). This evidence concerns the gene PPARG and diabetes mellitus.